Outcome of Video-assisted Thoracoscopic Surgery for Spontaneous Secondary Pneumothorax by Kim, Sung Jun et al.
Korean J Thorac Cardiovasc Surg 2011;44:225-228 □ Clinical Research □
DOI:10.5090/kjtcs.2011.44.3.225 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online)
− 225  −
*Department  of  Thoracic  and  Cardiovascular  Surgery,  College  of  Medicine,  Hallym  University
**Department  of  Thoracic  and  Cardiovascular  Surgery,  Kangnam  Sacred  Heart  Hospital,  College  of  Medicine,  Hallym  University
***Department  of  Thoracic  and  Cardiovascular  Surgery,  Chuncheon  Sacred  Heart  Hospital,  College  of  Medicine,  Hallym  University
****Department  of  Thoracic  and  Cardiovascular  Surgery,  Hangang  Sacred  Heart  Hospital,  College  of  Medicine,  Hallym  University
*****Department  of  Thoracic  and  Cardiovascular  Surgery,  Hallym  University  Sacred  Heart  Hospital,  College  of  Medicine,  Hallym  University
******Department  of  Thoracic  and  Cardiovascular  Surgery,  Kangdong  Sacred  Heart  Hospital,  College  of  Medicine,  Hallym  University
Received:  October  25,  2010,  Revised:  November  25,  2010,  Accepted :  M a y  1 1 ,  2 0 1 1
Corresponding  author: Hee-Sung  Lee,  Department  of  Thoracic  and  Cardiovascular  Surgery,  Kangnam  Sacred  Heart  Hospital,  College  of 
Medicine,  Hallym  University,  948-1,  Daerim-dong,  Yeongdeungpo-gu,  Seoul  150-950,  Korea
(Tel)  82-2-829-5138  (Fax)  82-2-849-4469  (E-mail)  lheecs@naver.com
 C  The  Korean  Society  for  Thoracic  and  Cardiovascular  Surgery.  2011.  All  right  reserved.
CC  This  is  an  open  access  article  distributed  under  the  terms  of  the  Creative  Commons  Attribution  Non-Commercial  License  (http://creative-
commons.org/licenses/by-nc/3.0)  which  permits  unrestricted  non-commercial  use,  distribution,  and  reproduction  in  any  medium,  provided  the 
original  work  is  properly  cited.
Outcome of Video-assisted Thoracoscopic Surgery
for Spontaneous Secondary Pneumothorax
Sung  Jun  Kim,  M.D.*,  Hee-Sung  Lee,  M.D.**,  Hyoung-Soo  Kim,  M.D.***,  Ho-Seung  Shin,  M.D.****,
Jae-Woong Lee, M.D.*****, Kun-Il Kim, M.D.*****, Sung-Woo Cho, M.D.******, Won Yong Lee, M.D.****
Background:  Conventional treatment (i.e. chest tube insertion and chemical pleurodesis) still remains standard for 
patients with secondary spontaneous pneumothorax because the risk of surgical bullectomy is deemed high in this 
subset. However, it has been suggested that surgical treatment using thoracoscopy may expedite postoperative re-
covery and, thus, may reduce hospital stay. Materials and Methods: Retrospective review of 61 patients with sec-
ondary spontaneous pneumothorax, who underwent conventional treatment (n=39) or video-assisted thoracoscopic 
surgery (VATS) (n=22) between January 2007 and December 2009, was performed. Talc was used for chemical 
pleurodesis in both groups. Results: Hospital stay of conventional treatment group and VATS group was 14.2±14.2 
days (4∼58 days) and 10.6±5.8 days (5∼32 days), respectively, with statistically significant difference (p=0.033). 
Recurrence rate of conventional treatment group was also significantly higher (12/39, 30%) compared to VATS 
group (1/22, 4.5%) (p=0.016). Conclusion: In selected patients with secondary spontaneous pneumothorax with con-
tinuous air leak or inadequate lung expansion, thoracoscopic surgery with chemical pleurodesis using talc results in 
shorter hospital stay and lower recurrence rate compared to conventional approach. 
Key words: 1. Pneumothorax
2. Thoracoscopy
3. Pleurodesis
INTRODUCTION
Differing  from  primary  spontaneous  pneumothorax,  secon-
dary  spontaneous  pneumothorax  is  characterized  by  the  asso-
ciation of underlying parenchymal lung lesions and multifocal 
bullae, which are not confined to the upper lobes but involv-
ing  multiple  lobes  [1].  Affecting  elderly  patients  [2]  whose 
pulmonary  function  is  frequently  compromised,  secondary 
pneumothorax has been thought to have a higher risk for sur-
gical  treatment  [3].  However,  conventional  approach  (i.e. 
chest  tube  insertion  and  chemical  pleurodesis)  may  be  asso-
ciated  with  persistent  air  leak,  severe  pain  from  repeated 
chemical  irritation,  prolonged  hospital  stay  and  high  compli-
cation  rate  [4,5].  Recently,  it  has  been  suggested  that  vid-Sung Jun Kim, et al
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Table 1. Characteristics of patients
Variable
Conventional 
treatment  group
VATS  group p-value
No.  of  patient
Sex
  M a l e
  F e m a l e
Age
Height  (cm)
Weight  (kg)
Body  mass  index
Laterality 
  L e f t
    Right
Smoking  (pack-years)
Pneumothorax 
episodes
Underlying  disease
  C O P D
  T b c
  D I L D
39
36
 3
71.8±9.16
165±5.8
55.2±9.6
20.1±2.9
15
24
26.5±21.5
1.5±1.1
17
21
 1
22
20
 3
61.3±8.46
166.4±7.5
61.6±9.7
22.2±3.1
 9
13
20.2±21.8
1.4±0.5
18
 3
 1
N.A.
0.848
＜0.001
0.751
0.017
0.010
0.851
0.280
0.580
N.A.
VATS=Video-assisted  thoracoscopic  surgery;  COPD=Chronic  ob-
structive  pulmonary  disease;  Tbc=Tuberculosis;  DILD=Diffuse 
interstitial  lung  disease;  N.A.=Not  applicable.
eo-assisted thoracoscopic surgery (VATS) may result in lower 
morbidity  and  mortality  even  in  patients  with  underlying  pa-
renchymal  lung  diseases.  In  this  study,  we  sought  to  de-
termine  the  outcome  of  VATS  for  secondary  spontaneous 
pneumothorax  in  comparison  to  conventional  approach. 
MATERIALS AND METHODS
Retrospective review of 61 senile patients (age ＞50 years) 
with  secondary  pneumothorax,  who  underwent  conventional 
treatment  (n=39)  or  video-assisted  thoracscopic  surgery 
(VATS)  (n=22)  between  January  2007  and  December  2009, 
was performed. Conventional treatment group consisted of pa-
tients  whose  air  leak  through  the  chest  tube  ceased  after  one 
or  two  episodes  of  chemical  pleurodesis,  and  VATS  group 
consisted  of  selected  patients  with  good  general  condition 
who  were  considered  as  having  a  higher  probability  of  con-
ventional  treatment  failure,  suc h  a s  p e r s i s t e n t  a i r  l e a k  f o r  
more  than  5  days,  inadequate  lung  expansion,  and  multiple 
bullae  on  chest  computed  tomography.  In  the  VATS  group, 
surgical  technique  was  utilized  to  excise  only  the  air-leaking 
bullae,  and  chemical  pleurodesis  using  talc  (2  g)  was 
performed. Under general anesthesia with double lumen endo-
tracheal tube (Robertshaw
Ⓡ) for one-lung ventilation, a trocar 
(11.5  mm)  was  placed  in  the  previous  chest  tube  site,  and 
thoracoscopy  was  introduced  through  the  trocar.  Once 
air-leaking  bullae  were  identified,  the  two  additional  trocars 
(11.5  mm  and  5  mm)  were  placed  according  to  the  location 
of the target bullae. Because of the multiplicity of bullous le-
sion in these patients, resection of all bullae is not technically 
feasible,  and,  thus,  we  attempted  to  excise  only  air-leaking 
bullae  by  wedge  resection using staplers.  When  pleural adhe-
sion  near  the  air-leaking  bullae  was  severe,  extensive  adhe-
siolysis  was  performed  so  as  not  to  cause  inadvertent  tear  of 
the  surrounding  visceral  pleura  upon  the  wedge  resection. 
Chemical  pleurodesis  using  talc  was  performed  prior  to  chest 
closure.  In  conventional  treatment  group,  talc  was  introduced 
into  the  chest  tube(s)  after  adequate  lung  expansion  was  as-
certained on chest X-ray. Data are presented as frequencies or 
means  with  standard  deviations.  For  the  comparison  of  the 
two  groups  (Table  1),  variables  such  as  age,  sex,  height, 
body  weight,  body  mass  index,  smoking  history,  hospital 
stay, recurrence of air leak, morbidity and mortality, were in-
cluded  for  analysis.  Chi-square  test  was  used  for  categorical 
variables,  and  student  t-test  was  used  for  continuous  varia-
bles.  Statistical  analysis  was  conducted  using  SPSS  (Version 
windows  18.0;  SPSS  Inc.,  Chicago,  USA),  and  a  p-value  of 
less  than  0.05  was  considered  statistically  significant. 
RESULTS
There  were  56  men  and  5  women:  36  men  among  39  pa-
tients in the conventional treatment group and 20 men among 
22  patients  in  the  VATS  group.  Underlying  lung  diseases 
were  chronic  obstructive  pulmonary  disease  (COPD)  in  35 
(35/61,  57.3%),  pulmonary  tuberculosis  (Tbc)  in  24  (24/61, 
39.3%),  and  diffuse  interstitial  lung  disease  (DILD)  in  2 
(2/61, 3.4%): 17 COPD, 21 Tbc, 1 DILD in the conventional 
treatment group and 18 COPD, 3 Tbc, 1 DILD in the VATS 
group. Age at treatment was 68.1±10.2 years (51∼89 years): 
71.8±9.16 years (53∼89 years) in the conventional treatment 
group and 61.3±8.4 years (51∼82 years) in the VATS group. VATS for Spontaneous Secondary Pneumothorax
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Table 2. Comparison of the treatment outcome between the two 
groups
Variable
Conventional 
treatment  group
VATS  group p-value
Hospital  stay  (days)
Recurrence
Morbidity
Mortality
14.2±14.2
12  (30.7%)
0
2  (5%)
10.6±5.8
1  (4.5%)
0
0
0.033
0.016
－
0.280
VATS=Video-assisted  thoracoscopic  surgery.
Smoking  history  was  26  pack-years  (0∼60)  in  the  conven-
tional  treatment  group  and  20  pack-years  (0∼60)  in  the 
VATS group. In the VATS group, no patient underwent open 
thoracotomy conversion from initial VATS trial, and no post-
operative  complication  was  noted.  Air  leak  in  the  chest  tube 
was  noted  for  4.0±2.0  days  preoperatively  and  2.2±1.8  days 
(0∼7 days) postoperatively in the VATS group. Hospital stay 
was  14.2±14.2  days  (4∼58  days)  in  the  conventional  treat-
ment  group  and  10.6±5.8  days  (5∼32  days)  in  the  VATS 
group,  with  significant  inter-group  difference  (p＜0.033). 
Recurrence of pneumothorax was noted in 12 patients (12/39, 
30%) in the conventional treatment group and 1 patient (1/22, 
4.5%)  in  the  VATS  group.  There  were  2  deaths  in  the  con-
ventional  treatment  group:  1  hospital  death  due  to  the  acute 
exacerbation of DILD and 1 late death due to the progression 
of  COPD  (Table  2). 
DISCUSSION
Spontaneous  pneumothorax  is  classified  as  primary  or  sec-
ondary  based  on  the  absence  or  presence  of  parenchymal 
lung  disease.  Differing  from  primary  pneumothorax  which  is 
prevalent  among  young  population,  secondary  pneumothorax 
occurs  more  frequently  in  the  elderly.  Most  common  under-
lying  parenchymal  lung  diseases  have  been  COPD  [6]  in 
western  countries  and  pulmonary  tuberculosis  [7,8]  in  the 
East,  but the  incidence of  spontaneous  pneumothorax  compli-
cating  pneumocystis  carinii  pneumonia  has  increased  recently 
in  western  countries  due  to  the  prevalence  of  acquired  im-
mune  deficiency  syndrome  [9].  Other  etiologies  include  idio-
pathic  pulmonary  fibrosis  [10],  ankylosing  spondylitis  [11], 
multiple  sclerosis  [12],  and  cystic  fibrosis  [13].  While  ther-
apeutic  algorithm  for  primary  spontaneous  pneumothorax  has 
been  well-established  [14],  treatment  of  secondary  pneumo-
thorax  has  remained  to  be  defined.  Because  of  the  marginal 
pulmonary  reserve  in  this  setting  [15,16],  victims  of  secon-
dary pneumothorax tend to show severe symptoms, and, thus, 
need urgent chest tube insertion [17,18]. Furthermore, prepon-
derance  of  this  condition  in  the  elderly  with  poor  general 
condition may preclude surgeons from performing early surgi-
cal  intervention,  which  in  turn  results  in  higher  incidence  of 
treatment  failure,  complication,  and  mortality  [18].  Although 
spontaneous  pneumothorax  is  mostly  treated  by  thoracoscopic 
approach,  VATS  necessitate  temporary  one-lung  ventilation, 
which may be poorly tolerated in patients with underlying pa-
renchymal  lung  disease.  Thus,  conventional  approach  (i.e. 
chest  tube insertion with chemical  pleurodesis)  has  long  been 
regarded  as  the  treatment  of  choice  for  secondary  pneumo-
thorax [3]. However, there might be a subset of patients with 
underlying  lung  disease  who  would  benefit  from  early  surgi-
cal intervention. We deem that following patients with secon-
dary  pneumothorax  would  best b e n e f i t  f r o m  V A T S :  p a t i e n t s  
in  good  clinical  condition,  patients  with  prolonged  air  leak 
longer than 5 days due to inadequate lung expansion, and pa-
tients with bullae on chest computed tomography. In our ser-
ies,  no  patient  developed  complication  or  recurrence  by  em-
ploying  these  inclusion  criteria.  Because  secondary  pneumo-
thorax  is  frequently  associated  with  diffuse  bullous  lesion, 
complete resection of the bullae is difficult. To minimize sur-
gical insult and operation time, we selectively removed bullae 
with  profuse  air-leak  on  air-leakage  test  upon  VATS 
procedure.  We  also  used  talc  [19]  for  chemical  pleurodesis, 
which  was  conducted  under  thoracoscopic  guidance.  Talc 
pleurodesis  should  be  performed  with  caution  because  this 
procedure may be associated with various complications, from 
mild  complications  such  as  temporary  fever  within  2  or  3 
days after the procedure to severe ones such as acute respira-
tory  distress  syndrome  [20],  none  of  which  was  observed  in 
our  series. 
Clinical  implication  of  our  study  may  be  undermined  by 
retrospective  nature  of  the  research  and  patient  selection  bias 
in favor of patients with good clinical condition. Nevertheless, 
reasonably  low  morbidity  and  mortality  after  VATS  for  sec-
ondary  pneumothorax  in  our  series  may  rationalize  the  appli-Sung Jun Kim, et al
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cation  of  surgical  approach  for  selected  patients.  Further  re-
search  to  determine  the  efficacy  of  VATS  for  secondary 
pnuemothorax  may  be  mandatory. 
CONCLUSION
In  treating  secondary  spontanteous  pneumothrax,  thoraco-
scopic  bullae  resection  and  chemical  pleurodesis  using  talc 
may reduce hospital stay and recurrence compared to conven-
tional  treatment. 
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